|1.20|| +0.04 / +3.45%|
PURE Bioscience, Inc. is engaged in the discovery, development and commercialization of bioscience products that provide solutions to global health challenges. Its technology platform is based on stabilized ionic silver and its products contain Silver Dihydrogen Citrate (SDC). The SDC is a broad-spectrum, non-toxic antimicrobial agent, which is manufactured as a liquid and delivered in various concentrations. The company also manufacture and sell SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products. PURE Bioscience as founded by Michael L. Krall on August 24, 1992 and is headquartered in El Cajon, CA.
|Henry R. Lambert||Chief Executive Officer & Director|
|Mark S. Elliott||VP, Chief Financial & Accounting Officer|
|Bridget Tinsley||Vice President-Market Development|
|Tom Myers||Executive VP-Marketing & Product Development|
|Cliff Wechsler||Executive Vice President-Sales|